DUBLIN--(BUSINESS WIRE)--The "Label-Free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chip), Software), Technology (Surface Plasmon Resonance), Application (Binding Kinetics), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global label-free detection market is projected to reach USD 626.4 million by 2025 from USD 431.7 million in 2020, at a CAGR of 7.7% during the forecast period.
Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.
By consumables type segment, the biosensor chips accounted for the fastest growing consumable segment of the label-free detection market
On the basis of product & service type, the consumables market is segmented into biosensor chips, microplates and reagents & kits. The biosensor chips accounted for the fastest-growing segment of the consumables segment mainly due to the high specificity and ability to monitor molecular interactions in real-time.
By application, the binding kinetics segment accounted for the largest share of the label-free detection market
Based on application, the label-free detection market is categorized into six segments-binding kinetics, binding thermodynamics, hit confirmation, lead generation, endogenous receptor detection, and other applications. The binding kinetics accounted for the largest share of application segment due to the increasing number of drug discovery research and development activities and increasing efforts to study biomolecular kinetics through label-free detection technologies.
Asia Pacific: The fastest-growing region in the label-free detection market.
The Asia Pacific region is estimated to grow at the highest CAGR in the label-free detection market during the forecast period, this is mainly due to rising awareness, increasing government support and funding, and growth in life science research.
North America: the largest share of the label-free detection market
North America accounted for the largest share of the label-free detection market The availability of funds for research, increasing research activities in drug discovery and development, growth in pharmaceutical R&D spending, and the presence of key players are the major factors driving the North American market.
- Introduction of Technologically Advanced Products
- Growing Number of Drug Discovery Programs Through Academic-Industrial Partnerships
- High Sensitivity of Label-Free Technologies
- High Cost of Instruments
- Growing Life Science Research Activities in Emerging Markets
- Shortage of Skilled Professionals
- Rising Pharmaceutical Outsourcing
- Impact of the Covid-19 Outbreak on the Label-Free Detection Market
- Sartorius Ag
- Waters Corporation
- Perkinelmer Inc.
- Ametek, Inc.
- Horiba, Ltd.
- Mettler Toledo
- Corning Incorporated
- Agilent Technologies, Inc.
- Nanotemper Technologies Gmbh
- Shimadzu Corporation
- Hitachi High-Tech Corporation
- Affinit Instruments
- Biosensing Instrument
- Bionavis Ltd.
- Creoptix Ag
- Bioptix Analytical Llc
- Wyatt Technology Corporation
For more information about this report visit https://www.researchandmarkets.com/r/4yze73